Autres langues Theratechnologies Inc. Nasdaq

Actions

THTX

CA88338H7040

Produits pharmaceutiques

Temps Différé Nasdaq 22:00:00 25/09/2025			Varia. 5j.	Varia. 1 janv.
3,390 ^USD	-.--%		-.--%	-

25/09/25	CB Biotechnology finalise l'acquisition de Theratechnologies Inc. (TSX:TH)	CI
25/09/25	Theratechnologies : retrait imminent du Nasdaq après l'acquisition par Future Pak	MT

Autres langues

05/12	"A Change Is A Change" – The Supreme Court Rejects A Narrow Interpretation Of "Material Change"
26/09/25	Theratechnologies Inc.(NasdaqCM:THTX) dropped from S&P Global BMI Index
25/09/25	CB Biotechnology, LLC completed the acquisition of Theratechnologies Inc. (TSX:TH).
25/09/25	Theratechnologies Shares to Be Delisted From Nasdaq After Future Pak Finalizes Acquisition
25/09/25	Theratechnologies Announces Completion of Acquisition by Future Pak
25/09/25	Theratechnologies Inc.(NasdaqCM:THTX) dropped from NASDAQ Composite Index
22/09/25	Theratechnologies Inc.(NasdaqCM:THTX) added to S&P Global BMI Index
16/09/25	Theratechnologies Gets Final Court Approval for Acquisition by Future Pak
16/09/25	Theratechnologies receives final court approval on to be acquired by Future Pak
16/09/25	Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
12/09/25	Theratechnologies Shareholders Approve Acquisition by Future Pak
12/09/25	Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak
05/09/25	Theratechnologies Inc. Announces Availability of EGRIFTA WR (tesamorelin) for Injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
05/09/25	Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval
05/09/25	Theratechnologies Brief: Announcing Availability Of EGRIFTA WR (Tesamorelin) For Injection To Reduce Excess Abdominal Fat In Adults With HIV And Lipodystrophy
05/09/25	Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
02/09/25	Theratechnologies Inc - ISS and Glass Lewis recommend voting 'for' Future PAK arrangement
02/09/25	Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
18/08/25	Theratechnologies Urges Shareholders to Vote in Favor of Future Pak Acquisition
18/08/25	Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
09/07/25	Theratechnologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2025
09/07/25	Theratechnologies : Q2 Interim Consolidated May 31, 2025vFINAL
09/07/25	Theratechnologies : MDA Q2 2025 VFINAL
09/07/25	Theratechnologies: Fiscal Q2 Earnings Snapshot
09/07/25	Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand